Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.50
+0.40 (2.65%)
At close: Mar 9, 2026, 4:00 PM EDT
15.68
+0.18 (1.19%)
After-hours: Mar 9, 2026, 5:14 PM EDT
Nurix Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | 2020 - 2018 |
| Cash & Equivalents | 246.96 | 110 | 54.63 | 64.47 | 80.51 | Upgrade
|
| Short-Term Investments | 345.98 | 499.59 | 233.28 | 244.67 | 215.21 | Upgrade
|
| Cash & Short-Term Investments | 592.94 | 609.58 | 287.91 | 309.14 | 295.72 | Upgrade
|
| Cash Growth | -2.73% | 111.73% | -6.87% | 4.54% | 5.18% | Upgrade
|
| Accounts Receivable | - | - | - | - | 6 | Upgrade
|
| Other Receivables | 1.5 | 1.5 | 0.8 | 1.1 | 1.1 | Upgrade
|
| Receivables | 1.5 | 1.5 | 0.8 | 1.1 | 7.1 | Upgrade
|
| Prepaid Expenses | 12.38 | 8.3 | 6.8 | 8.21 | 8.29 | Upgrade
|
| Total Current Assets | 606.82 | 619.39 | 295.5 | 318.45 | 311.12 | Upgrade
|
| Property, Plant & Equipment | 73.01 | 45.9 | 47.95 | 29.51 | 25.35 | Upgrade
|
| Long-Term Investments | - | - | 7.42 | 63.88 | 137.19 | Upgrade
|
| Long-Term Deferred Charges | 0.1 | 0.1 | 0.5 | 0.5 | 0.5 | Upgrade
|
| Other Long-Term Assets | 8.21 | 3.96 | 4.22 | 4.42 | 2.62 | Upgrade
|
| Total Assets | 688.14 | 669.34 | 355.6 | 416.76 | 476.77 | Upgrade
|
| Accounts Payable | 11.22 | 11.48 | 6.4 | 5.06 | 6.65 | Upgrade
|
| Accrued Expenses | 51.7 | 34.48 | 24.19 | 20.84 | 13.82 | Upgrade
|
| Current Portion of Leases | 2.82 | 8.01 | 7.49 | 5.53 | 3.85 | Upgrade
|
| Current Income Taxes Payable | 1.06 | 1.24 | 0.03 | 0.09 | 0.08 | Upgrade
|
| Current Unearned Revenue | 17.58 | 38.36 | 48.1 | 37.63 | 41.21 | Upgrade
|
| Other Current Liabilities | 2.1 | 2.28 | 0.75 | 1.5 | 0.66 | Upgrade
|
| Total Current Liabilities | 86.47 | 95.85 | 86.96 | 70.66 | 66.26 | Upgrade
|
| Long-Term Leases | 52.91 | 20.29 | 23.13 | 6.43 | 9.19 | Upgrade
|
| Long-Term Unearned Revenue | 10.01 | 26.21 | 45.02 | 35.97 | 59.02 | Upgrade
|
| Total Liabilities | 149.39 | 142.35 | 155.11 | 113.06 | 134.47 | Upgrade
|
| Common Stock | 0.1 | 0.08 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 1,542 | 1,266 | 746.3 | 709.22 | 563.76 | Upgrade
|
| Retained Earnings | -1,003 | -738.77 | -545.2 | -401.25 | -220.89 | Upgrade
|
| Comprehensive Income & Other | 0.11 | 0.15 | -0.66 | -4.32 | -0.61 | Upgrade
|
| Total Common Equity | 538.75 | 526.99 | 200.49 | 303.7 | 342.3 | Upgrade
|
| Shareholders' Equity | 538.75 | 526.99 | 200.49 | 303.7 | 342.3 | Upgrade
|
| Total Liabilities & Equity | 688.14 | 669.34 | 355.6 | 416.76 | 476.77 | Upgrade
|
| Total Debt | 55.73 | 28.3 | 30.61 | 11.96 | 13.04 | Upgrade
|
| Net Cash (Debt) | 537.21 | 581.28 | 264.72 | 361.06 | 419.87 | Upgrade
|
| Net Cash Growth | -7.58% | 119.59% | -26.68% | -14.01% | 49.34% | Upgrade
|
| Net Cash Per Share | 6.20 | 8.66 | 4.87 | 7.43 | 9.79 | Upgrade
|
| Filing Date Shares Outstanding | 102.84 | 75.89 | 48.89 | 47.27 | 44.74 | Upgrade
|
| Total Common Shares Outstanding | 101.81 | 75.87 | 48.72 | 47.17 | 44.66 | Upgrade
|
| Working Capital | 520.35 | 523.53 | 208.55 | 247.79 | 244.86 | Upgrade
|
| Book Value Per Share | 5.29 | 6.95 | 4.12 | 6.44 | 7.66 | Upgrade
|
| Tangible Book Value | 538.75 | 526.99 | 200.49 | 303.7 | 342.3 | Upgrade
|
| Tangible Book Value Per Share | 5.29 | 6.95 | 4.12 | 6.44 | 7.66 | Upgrade
|
| Machinery | 44.75 | 41.04 | 33.83 | 27.62 | 19.3 | Upgrade
|
| Leasehold Improvements | 9.37 | 5.14 | 3.24 | 3.83 | 3.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.